FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563485792> ?p ?o ?g. }

• W2563485792 endingPage "156" @default.
• W2563485792 startingPage "151" @default.
• W2563485792 abstract "To determine if cholesterol is a risk factor for the development of lower urinary tract symptoms in asymptomatic men.A post-hoc analysis of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study was carried out in 2323 men with baseline International Prostate Symptom Score <8 and not taking benign prostatic hyperplasia or cholesterol medications. Cox proportion models were used to test the association between cholesterol, high-density lipoprotein, low-density lipoprotein and the cholesterol : high-density lipoprotein ratio with incident lower urinary tract symptoms, defined as first report of medical treatment, surgery or two reports of an International Prostate Symptom Score >14.A total of 253 men (10.9%) developed incident lower urinary tract symptoms. On crude analysis, higher high-density lipoprotein was associated with a decreased lower urinary tract symptoms risk (hazard ratio 0.89, P = 0.024), whereas total cholesterol and low-density lipoprotein showed no association. After multivariable adjustment, the association between high-density lipoprotein and incident lower urinary tract symptoms remained significant (hazard ratio 0.89, P = 0.044), whereas no association was observed for low-density lipoprotein (P = 0.611). There was a trend for higher cholesterol to be linked with higher lower urinary tract symptoms risk, though this was not statistically significant (hazard ratio 1.04, P = 0.054). A higher cholesterol : high-density lipoprotein ratio was associated with increased lower urinary tract symptoms risk on crude (hazard ratio 1.11, P = 0.016) and adjusted models (hazard ratio 1.12, P = 0.012).Among asymptomatic men participating in the REDUCE study, higher cholesterol was associated with increased incident lower urinary tract symptoms risk, though the association was not significant. A higher cholesterol : high-density lipoprotein ratio was associated with increased incident lower urinary tract symptoms, whereas higher high-density lipoprotein was protective. These findings suggest dyslipidemia might play a role in lower urinary tract symptoms progression." @default.
• W2563485792 created "2017-01-06" @default.
• W2563485792 creator A5007476497 @default.
• W2563485792 creator A5033077569 @default.
• W2563485792 creator A5036003731 @default.
• W2563485792 creator A5039701124 @default.
• W2563485792 creator A5041601916 @default.
• W2563485792 creator A5051402370 @default.
• W2563485792 creator A5086081364 @default.
• W2563485792 date "2016-12-22" @default.
• W2563485792 modified "2023-09-26" @default.
• W2563485792 title "Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study" @default.
• W2563485792 cites W1986678910 @default.
• W2563485792 cites W1994659045 @default.
• W2563485792 cites W2037583918 @default.
• W2563485792 cites W2039915716 @default.
• W2563485792 cites W2045504344 @default.
• W2563485792 cites W2064819768 @default.
• W2563485792 cites W2067157352 @default.
• W2563485792 cites W2069605381 @default.
• W2563485792 cites W2075608594 @default.
• W2563485792 cites W2085238920 @default.
• W2563485792 cites W2131627141 @default.
• W2563485792 cites W2134130989 @default.
• W2563485792 cites W2134725999 @default.
• W2563485792 cites W2148015347 @default.
• W2563485792 cites W2153208592 @default.
• W2563485792 cites W2155530804 @default.
• W2563485792 cites W2156445049 @default.
• W2563485792 cites W2166667622 @default.
• W2563485792 cites W2170321998 @default.
• W2563485792 doi "https://doi.org/10.1111/iju.13265" @default.
• W2563485792 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28004415" @default.
• W2563485792 hasPublicationYear "2016" @default.
• W2563485792 type Work @default.
• W2563485792 sameAs 2563485792 @default.
• W2563485792 citedByCount "7" @default.
• W2563485792 countsByYear W25634857922018 @default.
• W2563485792 countsByYear W25634857922019 @default.
• W2563485792 countsByYear W25634857922020 @default.
• W2563485792 countsByYear W25634857922021 @default.
• W2563485792 countsByYear W25634857922022 @default.
• W2563485792 countsByYear W25634857922023 @default.
• W2563485792 crossrefType "journal-article" @default.
• W2563485792 hasAuthorship W2563485792A5007476497 @default.
• W2563485792 hasAuthorship W2563485792A5033077569 @default.
• W2563485792 hasAuthorship W2563485792A5036003731 @default.
• W2563485792 hasAuthorship W2563485792A5039701124 @default.
• W2563485792 hasAuthorship W2563485792A5041601916 @default.
• W2563485792 hasAuthorship W2563485792A5051402370 @default.
• W2563485792 hasAuthorship W2563485792A5086081364 @default.
• W2563485792 hasBestOaLocation W25634857921 @default.
• W2563485792 hasConcept C121608353 @default.
• W2563485792 hasConcept C126322002 @default.
• W2563485792 hasConcept C126894567 @default.
• W2563485792 hasConcept C134018914 @default.
• W2563485792 hasConcept C207103383 @default.
• W2563485792 hasConcept C2776235491 @default.
• W2563485792 hasConcept C2776547966 @default.
• W2563485792 hasConcept C2777910003 @default.
• W2563485792 hasConcept C2778163477 @default.
• W2563485792 hasConcept C2778878792 @default.
• W2563485792 hasConcept C2779478474 @default.
• W2563485792 hasConcept C2780192828 @default.
• W2563485792 hasConcept C44249647 @default.
• W2563485792 hasConcept C50382708 @default.
• W2563485792 hasConcept C50440223 @default.
• W2563485792 hasConcept C71924100 @default.
• W2563485792 hasConcept C77411442 @default.
• W2563485792 hasConcept C90924648 @default.
• W2563485792 hasConceptScore W2563485792C121608353 @default.
• W2563485792 hasConceptScore W2563485792C126322002 @default.
• W2563485792 hasConceptScore W2563485792C126894567 @default.
• W2563485792 hasConceptScore W2563485792C134018914 @default.
• W2563485792 hasConceptScore W2563485792C207103383 @default.
• W2563485792 hasConceptScore W2563485792C2776235491 @default.
• W2563485792 hasConceptScore W2563485792C2776547966 @default.
• W2563485792 hasConceptScore W2563485792C2777910003 @default.
• W2563485792 hasConceptScore W2563485792C2778163477 @default.
• W2563485792 hasConceptScore W2563485792C2778878792 @default.
• W2563485792 hasConceptScore W2563485792C2779478474 @default.
• W2563485792 hasConceptScore W2563485792C2780192828 @default.
• W2563485792 hasConceptScore W2563485792C44249647 @default.
• W2563485792 hasConceptScore W2563485792C50382708 @default.
• W2563485792 hasConceptScore W2563485792C50440223 @default.
• W2563485792 hasConceptScore W2563485792C71924100 @default.
• W2563485792 hasConceptScore W2563485792C77411442 @default.
• W2563485792 hasConceptScore W2563485792C90924648 @default.
• W2563485792 hasFunder F4320307773 @default.
• W2563485792 hasIssue "2" @default.
• W2563485792 hasLocation W25634857921 @default.
• W2563485792 hasLocation W25634857922 @default.
• W2563485792 hasOpenAccess W2563485792 @default.
• W2563485792 hasPrimaryLocation W25634857921 @default.
• W2563485792 hasRelatedWork W1979522210 @default.
• W2563485792 hasRelatedWork W2058677706 @default.
• W2563485792 hasRelatedWork W2085062461 @default.
• W2563485792 hasRelatedWork W2116616598 @default.

• next